C-Reactive Protein in Idiopathic Inflammatory Myopathies

References

• DeVere R, Bradley WG: Polymyositis: Its presentation, morbiditiy, and mortality. Brain 98: 637--66, 1975
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB, Bowman RL, Pearson CM: A computer assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255--86, 1977
   PubMed Web of Science ®Google Scholar
• Pearson CM, Bohan A: The spectrum of polymyositis and dermatomyositis. Med Clin North Am 61: 439–457, 1977
   Web of Science ®Google Scholar
• Edvards RHT, Isenberg DA, Wiles CM, Young A, Snaith ML: The investigation of inflammatory myopathy. J R Coll Phys London 15: 19–24, 1981
   Google Scholar
• Rider LG, Miller FW: Laboratory evaluation of the inflammatory myopathies. Clin Diagn Laborat Immunolog 9: 1–9, 1995
   Google Scholar
• Ruhenstroth-Bauer G, Schedler K, Scherer R, Vesterberg O: On the possibility of differential diagnosis at elevated erythrocyte sedimentation rate by analysis of the concentrations of blood plasma proteins – a model study. Clin Chem Clin Biochem 28: 845–850, 1990
   PubMedGoogle Scholar
• Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS: Acute proteins or tumor markers: The role of SAA, SAP, CRP, and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 19: 193–198, 1984
   PubMed Web of Science ®Google Scholar
• Dinant GJ, de Kock CA, van Wersch JW: Diagnostic value of C-reactive protein measurement does not justify replacement of the erythrocyte sedimentation rate in daily general practice. Eur J Clin Invest 25: 353–359, 1995
   Web of Science ®Google Scholar
• Putto A, Ruuskanen O, Meurman O, Ekblad H, Korvenrantra H, Mertsola J, Peltola H, et al.: C-reactive protein in the evaluation of febrile illness. Arch Dis Child 61: 24–29, 1986
   PubMed Web of Science ®Google Scholar
• Chen CH, Yu DT, Chou CT: Biomarkers in spondyloarthropathies. Adv Exp Med Biol 649: 122–132, 2009
   Web of Science ®Google Scholar
• Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW: The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 190: 585–590, 1999
   PubMed Web of Science ®Google Scholar
• van der Meer W, Pickkers P, Scott CS, van der Hoeven JG, Gunnewiek JK: Hematological indices, inflammatory markers and neutrophil CD64 expression: Comparative trends during experimental human endotoxemia. J Endotoxin Res 13: 94–100, 2007
   PubMedGoogle Scholar
• Imhof A, Fröhlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, Lowe GD, Koenig W: Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem 49: 669–672, 2003
   PubMed Web of Science ®Google Scholar
• Haas RH, Dyck RF, Dubowitz V, Pepys MB: C-reactive protein in childhood dermatomyositis. Ann Rheu Dis 41: 483–485, 1982
   Web of Science ®Google Scholar
• Mastaglia FL, Phillips BA: Idiopathic Inflammatory myopathies: Epidemiology, classification, and diagnostic criteria. Rheum Dis N Am 28: 723–741, 2002
   PubMed Web of Science ®Google Scholar
• Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP: Inclusion body myositis and myopathies. Ann Neurol 38: 705–713, 1995
   PubMed Web of Science ®Google Scholar
• Becker GJ, Waldburger M, Hughes GRV, Pepys MB: Value of C-reactive protein measurement in the investigation of fever in systemic lupus erythematodes. Ann Rheum Dis 39: 50–52, 1980
   PubMed Web of Science ®Google Scholar
• Louthrenoo W, Weerayutwattana N, Lertprasertsuke N, Sukitawut W: Serum muscle enzymes, muscle pathology and clinical muscle weakness: Correlation in Thai patients with polymyositis/dermatomyositis. J Med Assoc Thai 85: 26–32, 2002
   Google Scholar
• Amerio P, Girardelli CR, Proietto G, Forleo P, Ceritelli L, Feliciani C, Colonna L, et al.: Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol 12: 165–169, 2002
   Web of Science ®Google Scholar
• Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revutz J, Touraine R: Prognostic factors and predictive signs of malignancy in adult dermatomyositis – a study of 32 cases. Arch Dermatol 126: 633–637, 1990
   Google Scholar
• Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, Loustaud-Ratti V, et al.: Routine vs. estensive malignancy search for adult dermatomyositis and polymyositis. Arch Dermatol 138: 885–890, 2002
   PubMedGoogle Scholar
• Tienhaara A, Pulkki K, Mattila K, Irjala K, Pelliniemi T: Serum immunoreactive interleukin-6 and C-reacitve protein levels in patients with multiple myeloma at diagnosis. Br J Haematol 86: 391–393, 1994
   PubMed Web of Science ®Google Scholar